Heal the World

Asia's No.1 stool bank
Korea's No.1 FMT therapeutics developer

BioBankHealing operates Korea's No.1 stool bank and supplies its leading FMT therapeutics to hospitals across the country.

We are a biotech venture supplying FMT therapeutics already used in clinical patient treatment today, while developing next-generation microbiome therapeutics in parallel.

Explore the platform Contact us Become a donor

2016

Founded

2000+

Microbial strains

60+

Partner hospitals

Therapeutic areas

SNUBH

Bundang Hospital partnership

ABOUT

About us

BioBankHealing operates Korea's No.1 stool bank and is a biotech developing Korea's leading FMT therapeutics and next-generation microbiome therapeutics.

The gut microbes that coexist with the human body are the key determinant of health and disease.

Our microbiome platform and FMT technology are already treating patients in hospitals today.

Through continuous R&D, we aim to develop next-generation microbiome therapeutics and provide solutions spanning the full spectrum of care — from diseases modern medicine struggles to treat, to wellness care for a healthier life.

BioBankHealing will go on to become a global K-bio company.

Founded October 2016

Co-CEOs Dongho Lee
Wonsuk Lee

CORE VALUES

Challenge

We continually take on new paths that others have not traveled.

Creativity

We break free from fixed frameworks and pursue better solutions through open thinking.

Convergence

We create innovation through the collaboration of talented people across disciplines.

Respect

We respect ourselves and others, striving for a solid, trustworthy organization.

HISTORY

Our history

BioBankHealing's journey to advance human health.

BioBankHealing Co., Ltd. founded

Signed a formal FMT-solution supply agreement with SNU Bundang Hospital

Certified as a venture company

Investment from ActnerLab

Investment from the University of Ulsan angel investment fund

Selected for the TIPS program

R&D MOUs signed with Atlas Biomed, Dove Clinic, and Leiden University

Signed a joint-research agreement with Harvard Medical School (MGH)

Pre-Series A investment

Supply agreements signed with SNU branch hospitals, Soonchunhyang University Hospital, and Busan Paik Hospital

Human In Space Final Award — Excellence

Completed development of the FMT capsule

Conducted an IBS FMT clinical trial

Selected for the Post-TIPS program

Investment from Boryung Pharmaceutical

Conducting an FMT VRE patient clinical trial

Began supplying the FMT capsule

Advancing the Myolance health-functional-food business and the BBH016 raw-material supply business

LEADERSHIP

Leadership

BioBankHealing's leadership, guided together by SNU Bundang Hospital clinicians and management and science experts.

Wonsuk Lee

CEO · Head of Management

Dongho Lee

CEO · Head of R&D

Youngsoo Park

CTO · Head of Preclinical & Clinical Development

Sangyun Kim

CTO · Head of Preclinical & Clinical Development

Wonsuk Lee CEO

Ph.D. coursework, Graduate School of Convergence Science and Technology, Seoul National University
MBA (Master of Business Administration), Korea University
B.S. in Medical Science, University of Sydney

Dongho Lee CEO